30.52
전일 마감가:
$30.48
열려 있는:
$30.71
하루 거래량:
9,570
Relative Volume:
0.46
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.10%
1개월 성능:
-1.09%
6개월 성능:
-9.02%
1년 성능:
+18.55%
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Compare OZEM vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
30.52 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
365.76 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
740.96 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
742.61 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
293.07 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
722.51 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf 주식(OZEM)의 최신 뉴스
Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Trends
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - The Globe and Mail
TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant - TradingView
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain - The Globe and Mail
485BPOS: Post-effective amendment - Moomoo
3 Ways to Invest in the Growing GLP-1 Weight Loss Market - MarketBeat
Stock List: Research Stocks from Around the World - GuruFocus
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
OZEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
OZEM Stock Price, News & Analysis - Stock Titan
Can You Buy Ozempic Stock in 2026? - The Motley Fool
FDA Approves NVO's Increased Wegovy Dosage: Broaden Your Portfolio With These Healthcare ETFs - Bitget
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs - The Globe and Mail
Discipline and Rules-Based Execution in OZEM Response - Stock Traders Daily
Here are the quant ratings of OZEM’s top holdings amid Novo's selloff - MSN
OZEM stock: What the Ratings say (OZEM:NASDAQ) - Seeking Alpha
ETFs with Pfizer Inc. ( PFE ) Exposure - ETF Database
Behavioral Patterns of OZEM and Institutional Flows - Stock Traders Daily
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Short Interest Up 47.1% in January - Defense World
How to Invest in GLP-1 Stocks in 2026 - The Motley Fool
(OZEM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook - The Globe and Mail
NVO Receives FDA Approval for MASH Therapy: ETFs Expected to Benefit - intellectia.ai
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space? - Seeking Alpha
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most - Benzinga
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - MarketBeat
New Year, New Strategy: Navigating Weight Loss ETFs - ETF Database
Insiders Bullish on Certain Holdings of OZEM - Nasdaq
How Roundhill Etf Trust Glp-1 & Weight Loss Etf (OZEM) Affects Rotational Strategy Timing - Stock Traders Daily
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug - The Globe and Mail
6 Top-Performing ETF Areas of Last Week - sharewise.com
(OZEM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Best-Performing ETFs of November - TradingView — Track All Markets
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Eli Lilly Leads $150B Obesity Drug Race As Novo, Pfizer Battle; ETFs Poised To GainAbbVie (NYSE:ABBV) - Benzinga
Roundhill Glp 1 Weight Loss Etf (OZEM) 재무 분석
Roundhill Glp 1 Weight Loss Etf (OZEM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):